Category Biology/Biotechnology

New Strategy against Treatment-Resistant Prostate Cancer identified

A study from Washington University School of Medicine in St. Louis has identified an RNA molecule that suppresses prostate tumors. According to the research — conducted in mice implanted with human prostate tumor samples — restoring this so-called long noncoding RNA could be a new strategy to treat prostate cancer that has developed resistance to hormonal therapies. Pictured are prostate cancer cells. The androgen receptor is shown in dark red. Cell nuclei are outlined in blue. MAHAJAN LAB

A new study has identified an RNA molecule that suppresses prostate tumors. The scientists found that prostate cancers develop ways to shut down this RNA molecule to allow themselves to grow...

Read More

Gene Therapy boosts Parkinson’s Disease Drug Benefits

A new gene therapy targeting the small brain region where dopamine neurons reside, the substantia nigra, substantially boosts the benefits of the drug levodopa in Parkinson’s. The therapy restored the ability of these neurons to convert levodopa to dopamine. Scientists also showed how damage to the powerplants inside dopamine-releasing neurons triggers Parkinson’s. The findings may help identify humans in the earliest stages of Parkinson’s disease, develop therapies to slow disease progression and treat late-stage disease.

In late-stage Parkinson’s disease, the drug levodopa becomes less effective in treating symptoms because of the inexorable loss of dopamine-releasing neurons...

Read More

Combining two ‘Old Therapies’ packs a Powerful Punch against Pediatric Brain Tumors

On the left is a magnetic resonance image of a child’s medulloblastoma brain tumor, and on the right, a photomicrograph of medulloblastoma cells. The circle shows a Homer Wright rosette, a circular cluster of tumor cells characteristic of the disease. Johns Hopkins Medicine researchers have combined two old therapies — copper and disulfiram — to destroy this pediatric cancer. Credit: Graphic created by M.E. Newman, Johns Hopkins Medicine, using public domain images. MRI scan courtesy of the National Cancer Institute and photomicrograph courtesy of Jensflorian via Wikimedia Commons.

Copper has been clinically improving the lives of people since about 1500 BCE, when an Egyptian physician first recorded its use as a treatment for inflammation...

Read More

Artificial Intelligence to Detect Colorectal Cancer

A Tulane University researcher found that artificial intelligence can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study in the journal Nature Communications.

The study, which was conducted by researchers from Tulane, Central South University in China, the University of Oklahoma Health Sciences Center, Temple University, and Florida State University, was designed to test whether AI could be a tool to help pathologists keep pace with the rising demand for their services.

Pathologists evaluate and label thousands of histopathology images on a regular basis to tell whether someone has cancer...

Read More